These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 9587964)

  • 1. Isolation and identification of peptide degradation products of heat stressed pramlintide injection drug product.
    Hekman C; DeMond W; Dixit T; Mauch S; Nuechterlein M; Stepanenko A; Williams JD; Ye M
    Pharm Res; 1998 Apr; 15(4):650-9. PubMed ID: 9587964
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isolation and identification of cyclic imide and deamidation products in heat stressed pramlintide injection drug product.
    Hekman CM; DeMond WS; Kelley PJ; Mauch SF; Williams JD
    J Pharm Biomed Anal; 1999 Sep; 20(5):763-72. PubMed ID: 10701984
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kinetics of pramlintide degradation in aqueous solution as a function of temperature and pH.
    Kenley RA; Tracht S; Stepanenko A; Townsend M; L'Italien J
    AAPS PharmSciTech; 2000 Mar; 1(2):E7. PubMed ID: 14727840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Study of forced degradation behavior of pramlintide acetate by HPLC and LC-MS.
    Yuan Y; Li YB; Tai ZF; Xie YP; Pu XF; Gao J
    J Food Drug Anal; 2018 Jan; 26(1):409-415. PubMed ID: 29389581
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Orthogonal HPLC methods for quantitating related substances and degradation products of pramlintide.
    Demond W; Kenley RA; Italien JL; Lokensgard D; Weilersbacher G; Herman K
    AAPS PharmSciTech; 2000 Mar; 1(1):E6. PubMed ID: 14727855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The stability and degradation pathway of recombinant human parathyroid hormone: deamidation of asparaginyl residue and peptide bond cleavage at aspartyl and asparaginyl residues.
    Nabuchi Y; Fujiwara E; Kuboniwa H; Asoh Y; Ushio H
    Pharm Res; 1997 Dec; 14(12):1685-90. PubMed ID: 9453054
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Degradation of aspartic acid and asparagine residues in human growth hormone-releasing factor.
    Bongers J; Heimer EP; Lambros T; Pan YC; Campbell RM; Felix AM
    Int J Pept Protein Res; 1992 Apr; 39(4):364-74. PubMed ID: 1428526
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pramlintide injection drug product robustness studies.
    Kenley RA; Bancroft F; L'Italien J; Stepanenko A; Townsend M; Dixit T
    AAPS PharmSciTech; 2000 Mar; 1(2):E8. PubMed ID: 14727841
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced separation and characterization of deamidated peptides with RP-ERLIC-based multidimensional chromatography coupled with tandem mass spectrometry.
    Hao P; Qian J; Dutta B; Cheow ES; Sim KH; Meng W; Adav SS; Alpert A; Sze SK
    J Proteome Res; 2012 Mar; 11(3):1804-11. PubMed ID: 22239700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemical pathways of peptide degradation. II. Kinetics of deamidation of an asparaginyl residue in a model hexapeptide.
    Patel K; Borchardt RT
    Pharm Res; 1990 Jul; 7(7):703-11. PubMed ID: 2395797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amyloidogenesis of the amylin analogue pramlintide.
    da Silva DC; Fontes GN; Erthal LC; Lima LM
    Biophys Chem; 2016 Dec; 219():1-8. PubMed ID: 27665170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The relative rates of glutamine and asparagine deamidation in glucagon fragment 22-29 under acidic conditions.
    Joshi AB; Kirsch LE
    J Pharm Sci; 2002 Nov; 91(11):2331-45. PubMed ID: 12379918
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does deamidation of islet amyloid polypeptide accelerate amyloid fibril formation?
    Lam YPY; Wootton CA; Hands-Portman I; Wei J; Chiu CKC; Romero-Canelon I; Lermyte F; Barrow MP; O'Connor PB
    Chem Commun (Camb); 2018 Dec; 54(98):13853-13856. PubMed ID: 30474090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isolation and characterization of a succinimide variant of methionyl human growth hormone.
    Teshima G; Stults JT; Ling V; Canova-Davis E
    J Biol Chem; 1991 Jul; 266(21):13544-7. PubMed ID: 1856190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Formation of cyclic imide-like structures upon the treatment of calmodulin and a calmodulin peptide with heat.
    Martin BL; Wu D; Tabatabai L; Graves DJ
    Arch Biochem Biophys; 1990 Jan; 276(1):94-101. PubMed ID: 2105083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative measurement of deamidation in lens betaB2-crystallin and peptides by direct electrospray injection and fragmentation in a Fourier transform mass spectrometer.
    Robinson NE; Lampi KJ; McIver RT; Williams RH; Muster WC; Kruppa G; Robinson AB
    Mol Vis; 2005 Dec; 11():1211-9. PubMed ID: 16402021
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Zn(II) - pramlintide: Stability, binding sites and unexpected aggregation.
    Łoboda D; Rowińska-Żyrek M
    J Inorg Biochem; 2017 Sep; 174():150-155. PubMed ID: 28672144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LC-UV-PDA and LC-MS studies to characterize degradation products of glimepiride.
    Bansal G; Singh M; Jindal KC; Singh S
    J Pharm Biomed Anal; 2008 Nov; 48(3):788-95. PubMed ID: 18804934
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Physico-chemical properties of co-formulated fast-acting insulin with pramlintide.
    da Silva DC; Lima LMTR
    Int J Pharm; 2018 Aug; 547(1-2):621-629. PubMed ID: 29928940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The estimation of glutaminyl deamidation and aspartyl cleavage rates in glucagon.
    Joshi AB; Kirsch LE
    Int J Pharm; 2004 Apr; 273(1-2):213-9. PubMed ID: 15010145
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.